Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era

Open Access

Peer-reviewed

Research Article

Richard Kim,

Affiliation Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
⨯
Michael J. Schell,

Affiliation Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
⨯
Jamie K. Teer,

Affiliation Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
⨯
Danielle M. Greenawalt,

Current address: AstraZeneca, iMED Oncology, Waltham, MA, United States of America

Affiliation Merck Co, Inc., Boston, MA, United States of America
⨯
Mingli Yang,

Affiliation Gibbs Cancer Center and Research Institute, Spartanburg, SC, United States of America
⨯
Timothy J. Yeatman

* E-mail: yeatman@gibbscc.org

Affiliation Gibbs Cancer Center and Research Institute, Spartanburg, SC, United States of America
⨯

Reader Comments (0)

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Antigen-presenting cells
Is the Subject Area "Antigen-presenting cells" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Lymph
Is the Subject Area "Lymph" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.